rs730880732
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000355349.4(MYH7):c.2087A>G(p.Asn696Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N696H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000355349.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.2087A>G | p.Asn696Ser | missense_variant | 19/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.2087A>G | p.Asn696Ser | missense_variant | 18/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.2087A>G | p.Asn696Ser | missense_variant | 19/40 | 1 | NM_000257.4 | ENSP00000347507 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 17, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant is found within a region of MYH7 between codons 181 and 937 that contains the majority of the myosin head domain. Missense variants in this region have been shown to be significantly overrepresented in individuals with hypertrophic cardiomyopathy (PMID: 27532257). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 181173). This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 9822100, 28615295; Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 696 of the MYH7 protein (p.Asn696Ser). - |
Likely pathogenic, criteria provided, single submitter | research | Agnes Ginges Centre for Molecular Cardiology, Centenary Institute | Aug 24, 2018 | The MYH7 Asn696Ser variant has been reported previously in 6 HCM probands (GeneDx, Pers. Comm.; Jaaskelainen P, et al., 2014; Teirlinck CH, et al., 2012; Millat G, et al., 2010; Jaaskelainen P, et al., 1998). One of the probands was also reported to carry MYH7 Met982Thr (Millat G, et al., 2010), however this variant is found at high frequency in population databases (MAF=0.0009; http://exac.broadinstitute.org/), which is highly suggestive of a benign polymorphism. The MYH7 Asn696Ser is very rare, being absent from the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). We identified this variant in one HCM proband (Ingles J et al., 2017), who was diagnosed at 12 years after suffering a resuscitated cardiac arrest. The proband has no family history of HCM or sudden cardiac death, and neither of the parents were found to harbour this variant, therefore this variant has arisen de novo. Computational tools SIFT, PolyPhen-HCM, MutationTaster predict this variant to have a deleterious effect, however PolyPhen2 predicts this variant to be "benign". In a large HCM population study Walsh et al., showed that MYH7 variants identified in HCM cases were found to cluster between amino acids 181- 937 (2017), this implies that variants in this region are likely to cause a HCM phenotype. In summary, based on the adapted ACMG guidelines (Kelly MA, et al., 2018) the variant is located in a known functional domain of MYH7 (PM1), is rare in the general population (PM2), has been identified in a de novo case (PM6) and has been reported in a total of 7 HCM probands (PS4_moderate), therefore we classify MYH7 Asn696Ser as 'likely pathogenic'. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 30, 2022 | Identified in patients with HCM referred for genetic testing at GeneDx and in published literature (Jskelinen et al., 1998; Millat et al., 2010; Teirlinck et al., 2012; Ross et al., 2017; Mattivi et al., 2020); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23140321, 9822100, 24888384, 27532257, 29300372, 28615295, 28265379, 31006259, 32894683, 20800588) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at